Riabni
rituximab-arrx
- Strength
- 100 mg/10mL
- Form
- Injection, Solution
- Class
- CD20-directed Cytolytic Antibody
Amgen, Inc
Rituxan Hycela
rituximab and hyaluronidase
Listed by Genentech, Inc.
- Strength
- 2000 U/mL, 120 mg/mL
- Form
- Injection, Solution
- Route
- Subcutaneous
- Class
- CD20-directed Cytolytic Antibody; Endoglycosi…
What it contains
- Rituximab 2000 U/mL
- Hyaluronidase (human Recombinant) 120 mg/mL
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | CD20-directed Cytolytic Antibody; Endoglycosidase |
| Approval route | BLA — biologic licence |
| NDC code | 50242-109 |
| FDA application | BLA761064 |
| RxNorm concept | 1927885 |
| Package sizes listed | 1 |
| Marketed since | June 2017 |
Other products containing Rituximab
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Riabni
rituximab-arrx
- Strength
- 500 mg/50mL
- Form
- Injection, Solution
- Class
- CD20-directed Cytolytic Antibody
Amgen, Inc
Rituxan
rituximab
- Strength
- 10 mg/mL
- Form
- Injection, Solution
- Class
- CD20-directed Cytolytic Antibody
Genentech, Inc.
Rituxan
rituximab
- Strength
- 10 mg/mL
- Form
- Injection, Solution
- Class
- CD20-directed Cytolytic Antibody
Genentech, Inc.
Ruxience
rituximab-pvvr
- Strength
- 100 mg/10mL
- Form
- Injection, Solution
- Class
- CD20-directed Cytolytic Antibody
Pfizer Laboratories Div Pfizer Inc
Ruxience
rituximab-pvvr
- Strength
- 500 mg/50mL
- Form
- Injection, Solution
- Class
- CD20-directed Cytolytic Antibody
Pfizer Laboratories Div Pfizer Inc
Truxima
rituximab-abbs
- Strength
- 10 mg/mL
- Form
- Injection, Solution
- Class
- CD20-directed Cytolytic Antibody
Cephalon, Inc.
Truxima
rituximab-abbs
- Strength
- 10 mg/mL
- Form
- Injection, Solution
- Class
- CD20-directed Cytolytic Antibody
Cephalon, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.